Growth Metrics

Solid Biosciences (SLDB) Total Non-Current Liabilities: 2018-2023

Historic Total Non-Current Liabilities for Solid Biosciences (SLDB) over the last 4 years, with Dec 2023 value amounting to $23.9 million.

  • Solid Biosciences' Total Non-Current Liabilities was N/A to $21.9 million in Q3 2024 from the same period last year, while for Sep 2024 it was $21.9 million, marking a year-over-year change of. This contributed to the annual value of $23.9 million for FY2023, which is 50.63% down from last year.
  • Latest data reveals that Solid Biosciences reported Total Non-Current Liabilities of $23.9 million as of FY2023, which was down 50.63% from $48.5 million recorded in FY2022.
  • Solid Biosciences' 5-year Total Non-Current Liabilities high stood at $48.5 million for FY2022, and its period low was $23.9 million during FY2023.
  • Its 2-year average for Total Non-Current Liabilities is $36.2 million, with a median of $36.2 million in 2022.
  • Data for Solid Biosciences' Total Non-Current Liabilities shows a maximum YoY tumbled of 50.63% (in 2023) over the last 5 years.
  • Solid Biosciences' Total Non-Current Liabilities (Yearly) stood at $37.8 million in 2020, then reached $48.5 million in 2022, then crashed by 50.63% to $23.9 million in 2023.